|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.92 CNY | +1.96% |
|
+11.85% | -10.47% |
| Apr. 02 | Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023. | CI |
| Feb. 29 | Bloomage Biotech Names CFO | MT |
Bloomage BioTechnology Corporation Limited (SHSE:688363) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its A shares. The shares will be repurchased at a price of not more than CNY 130 per share.
The repurchased shares will be used for equity incentive and/or employee shareholding plan. The program is subject approval by the board of directors. The repurchase program is valid for 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.47% | 3.98B | |
| -4.06% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +55.96% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +3.45% | 8.71B |
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED 
